vascuCAP vs VX1+
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (vascuCAP) is designed for non-invasive CT angiography analysis to quantify plaque and assess cardiovascular risk, aiding in treatment decisions for atherosclerotic disease. In contrast, Tool B (VX1+) provides real-time AI assistance to electrophysiologists during cardiac ablation procedures for atrial fibrillation and tachycardia, focusing on guiding interventions for arrhythmias. While both are cardiology AI tools, their distinct applications in diagnosis/risk assessment versus intra-procedural guidance make them suitable for different clinical needs.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
vascuCAP (now ElucidVivo/PlaqueIQ) is an AI software for non-invasive CT angiography analysis, quantifying plaque composition and assessing cardiovascular risk to optimize treatment decisions. VX1+ is an AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
vascuCAP is designed for Cardiology, Radiology, and Vascular Surgery specialties. VX1+ is specifically intended for Cardiology, particularly assisting electrophysiologists during ablation procedures.
vascuCAP offers DICOM integration and PACS/EMR interoperability. VX1+ integrates with existing EP recording and 3D mapping systems and is compatible with specific data acquisition systems such as Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system.
vascuCAP analyzes non-invasive CT angiogram data to quantify and characterize plaque, including lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage. VX1+ analyzes electrograms to identify spatio-temporal dispersed electrograms (DEs) and provides cycle length estimation during AF and AT procedures.
VX1+ provides AI-driven insights to assist electrophysiologists in real-time during cardiac ablation procedures. vascuCAP is an analysis tool for non-invasive CT angiography, primarily used for diagnostic imaging and risk assessment rather than real-time procedural guidance.